Life insurance as an asset class: the honest IRR of whole life

No financial product generates more heat and less light than whole life insurance. Agents present it as a tax-advantaged asset class with guaranteed growth; critics call it a commission delivery vehicle wearing a policy. The honest answer requires a number both camps avoid quoting: the internal rate of return on your premiums, measured at specific holding periods. Run that number and whole life resolves into something unglamorous — a bond-like asset with a brutal front-loaded cost structure that loses badly for a decade, grudgingly breaks even in the second decade, and eventually delivers modest fixed-income returns for the small minority of buyers who hold it for thirty-plus years. Every part of the controversy lives in that trajectory.

The IRR curve: where the years go

A whole life policy's cash value IRR follows a signature arc. Years 1-5: deeply negative — the first year's premium goes overwhelmingly to the agent's commission and policy costs, and cash value is often near zero after year one. Years 8-12: crossing zero — cumulative cash value finally catches cumulative premiums somewhere around year 10 for a typical policy from a strong mutual insurer. Year 20: roughly 2-3.5% annualized on cash value. Year 30-40: perhaps 4-5% — converging toward, but rarely exceeding, long-run investment-grade bond returns. The death benefit IRR runs higher (dying early is, grimly, the product's best-performing scenario), but as a living asset class, whole life is a bond fund you paid a decade of returns to enter.

The statistic that decides the argument

Here is the uncomfortable centerpiece: industry persistency data has long shown that a large fraction of whole life policies — commonly estimated at 25-40% — lapse or surrender within the first ten years, and the share that survives to year 30 is a minority. Recall the IRR curve: the first ten years are exactly where the product punishes exit. This means the modal real-world outcome of a whole life purchase is not the year-30 illustration the agent presented — it's a loss taken somewhere on the curve's ugly left side. The product isn't dishonest about its long-run math; the sales process is dishonest about the odds that any given buyer reaches the long run.

The agent-incentive problem, stated plainly

Whole life commissions typically run 50-110% of the first year's premium, plus smaller renewals — versus a one-time commission on term insurance that is a small fraction of that, on a premium that is itself 90-95% smaller. An agent who sells you a $10,000/year whole life policy might earn $8,000; the $600/year term policy covering the same death benefit might pay a few hundred dollars. This doesn't make agents villains — it makes the recommendation unreliable, in exactly the way a doctor's advice would be unreliable if surgery paid 25 times what physical therapy did. The tell is universal: if the pitch leads with 'be your own bank,' tax-free retirement income, or infinite banking — rather than with a specific permanent insurance need you articulated — you are the commission's target market, not the product's.

• Demand the guaranteed column: illustrations show a guaranteed scenario and a current-dividend scenario. The guaranteed column is the contract; the other column is marketing with actuarial fonts.
• Ask for the year-by-year IRR of cash value and death benefit — insurers can produce it, and reluctance to show it is an answer in itself.
• Compare against the honest alternative: buy term, invest the premium difference in bonds (the fair comparison — not stocks) inside your remaining tax-advantaged space.
• If you want the asset class at lower cost, ask a fee-only advisor about low-load policies from direct insurers — stripping most of the commission moves breakeven years earlier.
• Already own a policy past year 10-12? The sunk costs are sunk and the forward-looking IRR is often decent — surrendering a mature policy to 'fix' an old mistake frequently creates a new one. Get a forward-IRR analysis before acting.

The bottom line

Assessed honestly, whole life is a front-loaded, illiquid bond substitute: strongly negative returns for a decade, breakeven around year ten, and 3-5% annualized only for the minority who hold three decades or more — a minority that persistency data says most buyers will not join. The math can work for high earners with maxed tax shelters, permanent insurance needs, and certain long holds; it cannot work as a substitute for cheap term insurance plus real investing, which is how it's most often sold. Judge the product by its guaranteed column and its ten-year exit odds, not its year-40 illustration — and judge the recommendation by remembering who gets paid what, and when.